References
- Bazilevsky GA, Affronti HC, Wei X, Campbell SL, Wellen KE, Marmorstein R. 2019. ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis. J Biol Chem. 294(18):7259–7268.
- Burke AC, Telford DE, Huff MW. 2019. Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol. 30(1):1–9.
- Chen ZH, Zhang H, Tao SH, Luo Z, Zhong CQ, Guo LB. 2015. Norlignans from Pouzolzia zeylanica var. microphylla and their nitric oxide inhibitory activity. J Asian Nat Prod Res. 17(10):959–966.
- Deng Z, Wong NK, Guo Z, Zou K, Xiao Y, Zhou Y. 2019. Dehydrocurvularin is a potent antineoplastic agent irreversibly blocking ATP-citrate lyase: evidence from chemoproteomics. Chem Commun. 55(29):4194–4197.
- Endo A, Kuroda M, Tsujita Y. 1976. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo). 29(12):1346–1348.
- Feng X, Zhang L, Xu S, Shen AZ. 2020. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: an updated review. Prog Lipid Res. 77:101006.
- Granchi C. 2022. ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective. Expert Opin Ther Pat. 32(7):731–742.
- Guan X, Liu M, Shao Z, Li H, Ran L, Li W. 2019. Efficient synthesis of several natural oligostilbenes from the biomimetic oxidation of brominated isorhapontigenin. Synthesis. 51(08):1825–1831.
- Huang JC, Liu YN, Tao YH, Chen BY, Lei C, Fu W, Li JY, Hu X, Hou AJ. 2021. Acylphloroglucinol derivatives with ATP citrate lyase inhibitory activities from Syzygium oblatum Wall. Phytochemistry. 187:112765.
- Jiang H, Hou T, Han Y, Lu SB, Liu L, Li DX, Zhu YH, Huang H, Li WJ, Xue XY, et al. 2023. Preparation and identification of isoquinoline alkaloids with ATP citrate lyase inhibitory activity from Dactylicapnos scandens. Fitoterapia. 165:105397.
- Ma J, Zheng Y, Tang W, Yan W, Nie H, Fang J, Liu G. 2020. Dietary polyphenols in lipid metabolism: a role of gut microbiome. Anim Nutr. 6(4):404–409.
- Mo CM, Chen XM, Guo LB, Tao SH, Chen YF. 2019. Study on chemical constituents from Pouzolzia zeylanica var. microphylla. Chin Tradit Herbal Drugs. 50:1294–1298.
- Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. 2009. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Comput Chem. 16:2785–2791.
- Newman DJ, Cragg GM. 2020. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 83(3):770–803.
- Nhung LTH, Huong PTM, Anh NT, Tai BH, Nhiem NX, Doan VV, Hoang NH, Seo Y, Kim SH, Kiem PV. 2022. Two new norlignans from the aerial parts of Pouzolzia sanguinea (Blume) Merr. Nat Prod Res. 36(1):157–164.
- Nugroho AE, Morita H. 2014. Circular dichroism calculation for natural products. J Nat Med. 68(1):1–10.
- Pescitelli G, Bruhn T. 2016. Good computational practice in the assignment of absolute configurations by TDDFT calculations of ECD spectra. Chirality. 28(6):466–474.
- Song T, Wang P, Li C, Jia L, Liang Q, Cao Y, Dong P, Shi H, Jiang M. 2021. Salidroside simultaneously reduces de novo lipogenesis and cholesterol biosynthesis to attenuate atherosclerosis in mice. Biomed Pharmacother. 134:111137.
- Wang P, Peng X, Hou T, Xu F, Zhou H, Yu Y, Qiu M, Liu Y, Zhao Y, Guo Z, et al. 2022. Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay. Chem Biol Interact. 367:110199.
- Wei X, Schultz K, Bazilevsky GA, Vogt A, Marmorstein R. 2020. Molecular basis for acetyl-CoA production by ATP-citrate lyase. Nat Struct Mol Biol. 27(1):33–41.
- Zhong CQ, Tao SH, Yi ZB, Guo LB, Xie YF, Chen YF. 2015. Four new compounds from Pouzolzia zeylanica (L.) Benn var. Microphylla. Heterocycles. 91(10):1926–1936.